A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease
Clinical trial NCT06077968 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06077968
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-01
- Primary completion
- 2029-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.